Literature DB >> 10604569

Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions.

C Hézode1, C Cazeneuve, O Coué, F Roudot-Thoraval, I Lonjon, A Bastie, C Duvoux, J M Pawlotsky, E S Zafrani, S Amselem, D Dhumeaux.   

Abstract

BACKGROUND/AIMS: Liver iron accumulation has been described in patients with chronic active hepatitis (CAH) C, and could play a role in the course of liver disease and negatively influence the response to interferon. The aim of this study was to determine the prevalence and severity of liver iron accumulation in CAH C, to assess its relationship with the HFE C282Y and H63D mutations, and to study its interactions with hepatic histological lesions.
METHODS: Two hundred and nine patients (131 men, 78 women, mean age 44.3+/-12.0 years) with CAH C, including 19 patients with cirrhosis (9.1%) were studied. A semiquantitative grading system from 0 to 3 was used for histological assessment of liver iron accumulation on Perls' staining. The HFE C282Y and H63D mutations were screened for by restriction enzyme analysis performed on PCR-amplified products. Histological scores of activity and fibrosis were determined according to a previously validated METAVIR score system.
RESULTS: Liver iron accumulation was found in 88/209 patients (42.1%), and was generally mild. The C282Y and H63D allele frequencies were in 23 (11.0%), and 50 (23.9%), respectively. No association was found between the presence of liver iron accumulation and the detection of the C282Y and H63D mutations. A significant relationship was found between the severity of histological activity and liver iron accumulation of macrophagic or mixed (i.e. both macrophagic and hepatocytic) type (p = 0.04). Although the number of cirrhotic patients was small, cirrhosis was more frequently observed in patients with than without liver iron accumulation (17.2% vs. 3.3%, p = 0.004).
CONCLUSIONS: Overall, these data suggest that the liver iron accumulation in patients with CAH C is significantly associated with histological activity and cirrhosis, whereas the two missense hemochromatosis gene mutations are not major determinants.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10604569     DOI: 10.1016/s0168-8278(99)80308-0

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  24 in total

1.  Effectiveness of oral iron to manage anemia in long-term hemodialysis patients with the use of ultrapure dialysate.

Authors:  Akiyasu Tsuchida; Bishnuhari Paudyal; Pramila Paudyal; Yoshitaka Ishii; Keiju Hiromura; Yoshihisa Nojima; Minoru Komai
Journal:  Exp Ther Med       Date:  2010-07-20       Impact factor: 2.447

2.  Influence of iron on the severity of hepatic fibrosis in patients with chronic hepatitis C.

Authors:  Tsung-Jung Lin; Li-Ying Liao; Shyr-Yi Lin; Chih-Lin Lin; Ting-An Chang
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

3.  Serum iron levels and hepatic iron overload in nonalcoholic steatohepatitis and chronic viral hepatitis.

Authors:  Suleyman Uraz; Cem Aygun; Abdullah Sonsuz; Gulsen Ozbay
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

4.  The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C.

Authors:  D Thorburn; G Curry; R Spooner; E Spence; K Oien; D Halls; R Fox; E A B McCruden; R N M MacSween; P R Mills
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

Review 5.  Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.

Authors:  Jinah Choi; Nicole L B Corder; Bhargav Koduru; Yiyan Wang
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

Review 6.  The role of iron in the pathophysiology and treatment of chronic hepatitis C.

Authors:  Leslie Price; Kris V Kowdley
Journal:  Can J Gastroenterol       Date:  2009-12       Impact factor: 3.522

7.  Iron increases translation initiation directed by internal ribosome entry site of hepatitis C virus.

Authors:  Hana Cho; Hyung Chul Lee; Sung Key Jang; Yoon Ki Kim
Journal:  Virus Genes       Date:  2008-06-20       Impact factor: 2.332

8.  Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype.

Authors:  Sven G Gehrke; Wolfgang Stremmel; Inge Mathes; Hans-Dieter Riedel; Karin Bents; Birgit Kallinowski
Journal:  J Mol Med (Berl)       Date:  2003-10-14       Impact factor: 4.599

9.  An antioxidant resveratrol significantly enhanced replication of hepatitis C virus.

Authors:  Mitsuyasu Nakamura; Hidetsugu Saito; Masanori Ikeda; Ryota Hokari; Nobuyuki Kato; Toshifumi Hibi; Soichiro Miura
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

10.  Factors affecting serum concentrations of hepatitis C virus (HCV) RNA in HCV genotype 1-infected patients with chronic hepatitis.

Authors:  John R Ticehurst; Fayez M Hamzeh; David L Thomas
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.